APA

Goldberg M. R., Lee Y., Vyas K. P., Slaughter D. E., Panebianco D., Ermlich S. J., Shadle C. R., Brucker M. J., McLoughlin D. A. & Olah T. V. (20000224). Rizatriptan, a novel 5-HT1B/1D agonist for migraine: single- and multiple-dose tolerability and pharmacokinetics in healthy subjects. : Journal of clinical pharmacology.

Chicago

Goldberg M R, Lee Y, Vyas K P, Slaughter D E, Panebianco D, Ermlich S J, Shadle C R, Brucker M J, McLoughlin D A and Olah T V. 20000224. Rizatriptan, a novel 5-HT1B/1D agonist for migraine: single- and multiple-dose tolerability and pharmacokinetics in healthy subjects. : Journal of clinical pharmacology.

Harvard

Goldberg M. R., Lee Y., Vyas K. P., Slaughter D. E., Panebianco D., Ermlich S. J., Shadle C. R., Brucker M. J., McLoughlin D. A. and Olah T. V. (20000224). Rizatriptan, a novel 5-HT1B/1D agonist for migraine: single- and multiple-dose tolerability and pharmacokinetics in healthy subjects. : Journal of clinical pharmacology.

MLA

Goldberg M R, Lee Y, Vyas K P, Slaughter D E, Panebianco D, Ermlich S J, Shadle C R, Brucker M J, McLoughlin D A and Olah T V. Rizatriptan, a novel 5-HT1B/1D agonist for migraine: single- and multiple-dose tolerability and pharmacokinetics in healthy subjects. : Journal of clinical pharmacology. 20000224.